Virtually Tripping. The first panel discussion at 7 October’s Psych Investor Summit: Data & Technology explored the application of virtual reality technology in psychedelic healthcare. The discussion was hosted by author Zoe Cormier.
Joe Hardy, Chief Science Officer at aNUma, was joined by TRIPP’s CEO Nanea Reeves and David Glowacki from CiTIUS.
About Joe Hardy, Chief Science Officer at aNUma:
Dr. Joe Hardy is a Cognitive Psychologist with a PhD from UC Berkeley, where he also received his MBA. For the past 15 years, he has been an industry thought leader, developing a variety of products at the intersection of brain science and technology.
About Nanea Reeves, CEO at TRIPP:
As CEO of TRIPP, the digital psychedelic platform that fully immerses individuals into alternate realities designed to support emotional and mental wellbeing, Nanea has over 15 years’ experience in tech leadership roles and that has helped to deliver over US$1.16b in exits.
About David Glowacki, Researcher at CiTIUS:
David Glowacki is a cross-disciplinary computer scientist, with interests that span nanoscience, aesthetics, cultural theory and psychology. He is a world leader in VR applied to interactive scientific simulation and visualisation, and founder of the Intangible Realities Laboratory, a research group working at the immersive frontiers of scientific, aesthetic, computational, and technological practice.
About Zoe Cormier:
Zoe Cormier is an author, journalist and public speaker with a background in biology. Her first book, Sex, Drugs and Rock n’ Roll: The Science of Hedonism and the Hedonism of Science – hand-picked by The Guardian as a must-read science book – was published by Profile in August 2014.
About PSYCH:
PSYCH is a premium business-to-business media and content platform for the psychedelic science and healthcare industry.
As our collective understanding of and attitudes towards psychedelics shift dramatically, we are witnessing a global rise in clinical trials, academic research and commercial investment. PSYCH tracks key psychedelic players, innovations and milestones, providing market insights to help investors make informed decisions.
Psychedelics are poised to disrupt the way we approach healthcare. To learn more about PSYCH, access our industry-leading events, subscribe to the most widely read psychedelics industry newsletter, or download The Psychedelics as Medicine Report.
Web: https://psych.global/
Twitter: https://twitter.com/psychglobal_
LinkedIn: https://www.linkedin.com/company/psych
0 Comments